AnnBarbaraMongeyMD

PubMed

• Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus.
  Brunner, H. I., Bishnoi, A., Barron, A. C., Houk, L. J., Ware, A., Farhey, Y., Mongey, A. B., Strife, C. F., Graham, T. B., Passo, M. H.> ;Lupus. 2006
• In vitro production of antibodies to histones in patients receiving chronic procainamide therapy.
  Mongey, A. B., Hess, E.> ;J Rheumatol. 2001 Sep
• Unusual presentation of polyarteritis nodosa.
  Hall, C., Mongey, A. B.> ;J Rheumatol. 2001 Apr
• Acetylation status is associated with serological changes but not clinically significant disease in patients receiving procainamide.
  Mongey, A. B., Sim, E., Risch, A., Hess, E.> ;J Rheumatol. 1999 Aug
• Genetic and immunologic studies of patients on procainamide.
  Adams, L. E., Balakrishnan, K., Malik, S., Mongey, A. B., Whitacre, L., Hess, E. V.> ;Hum Immunol. 1998 Mar
• Lupus and cerebrovascular accidents.
  Ware, A. E., Mongey, A. B.> ;Lupus. 1997
• High prevalence of antiphospholipid antibodies in patients taking procainamide.
  Merrill, J. T., Shen, C., Gugnani, M., Lahita, R. G., Mongey, A. B.> ;J Rheumatol. 1997 Jun
• Genetic, immunologic and biotransformation studies of patients on procainamide.
  Adams, L. E., Balakrishnan, K., Roberts, S. M., Belcher, R., Mongey, A. B., Thomas, T. J., Hess, E. V.> ;Lupus. 1993 Apr
• Drug and environmental effects on the induction of autoimmunity.
  Mongey, A. B., Hess, E. V.> ;J Lab Clin Med. 1993 Dec
• A prospective study of neurophysiologic, neurologic and immunologic abnormalities in systemic lupus erythematosus.
  McNicholl, J. M., Glynn, D., Mongey, A. B., Hutchinson, M., Bresnihan, B.> ;J Rheumatol. 1994 Jun
• Sulphasalazine-induced systemic lupus erythematosus.
  Mongey, A. B., Hess, E. V.> ;Br J Rheumatol. 1994 Aug
• Role of genetic factors in drug-related autoimmunity.
  Adams, L. E., Mongey, A. B.> ;Lupus. 1994 Dec
• Resection of bronchial neoplasm in the elderly.
  Mongey, A. B., Shaw, K., Luke, D., Clancy, L.> ;Ir Med J. 1986 Nov 01
• Juvenile chronic arthritis associated with systemic vasculitis.
  Cullen, B., Mongey, A. B., Molony, J.> ;Ir Med J. 1986 Mar
• Clinical neurophysiology in the assessment of neurological symptoms in systemic lupus erythematosus.
  Mongey, A. B., Glynn, D., Hutchinson, M., Bresnihan, B.> ;Rheumatol Int. 1987
• Advances in rheumatology.
  Mongey, A. B., Hess, E. V.> ;Radiol Clin North Am. 1988 Nov
• Drug-related lupus.
  Mongey, A. B., Hess, E. V.> ;Curr Opin Rheumatol. 1989 Oct
• Antinuclear antibodies and disease specificity.
  Mongey, A. B., Hess, E. V.> ;Adv Intern Med. 1991
• Drug-related lupus.
  Hess, E. V., Mongey, A. B.> ;Bull Rheum Dis. 1991
• Serologic evaluation of patients receiving procainamide.
  Mongey, A. B., Donovan-Brand, R., Thomas, T. J., Adams, L. E., Hess, E. V.> ;Arthritis Rheum. 1992 Feb
• Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection.
  Wheeler, J. F., Adams, L. E., Mongey, A. B., Roberts, S. M., Heineman, W. R., Hess, E. V.> ;Drug Metab Dispos. 1991 May 01
• Is the development of drug-related lupus a contraindication for switching from one TNF alpha inhibitor to another?
  Kocharla, L., Mongey, A. B.> ;Lupus. 2009 Feb 01
• Importance of drugs and environmental agents in Lupus.
  Mongey, A. B., Hess, E. V.> ;Lupus. 2007
• Randomised controlled trial examining the effect of exercise in people with rheumatoid arthritis taking anti-TNFα therapy medication.
  Reid, A., Brady, A., Blake, C., Mongey, A. B., Veale, D. J., FitzGerald, O., Cusack, T.> ;BMC Musculoskelet Disord. 2011
• Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus.
  Nicolaou, S. A., Neumeier, L., Takimoto, K., Lee, S. M., Duncan, H. J., Kant, S. K., Mongey, A. B., Filipovich, A. H., Conforti, L.> ;Cell Calcium. 2010 Jan 01
• Join now to see all